FL H0159

Licensed pharmacists are authorized to screen adults for HIV exposure and provide results, with advice to consult a physician, and may dispense HIV preexposure prophylaxis (PrEP) drugs pursuant to a valid prescription.

Pharmacists certified by the Board of Pharmacy may order and dispense HIV postexposure prophylaxis (PEP) drugs under a written collaborative practice agreement with a licensed physician, which must include terms on screening, patient categories, recordkeeping, and a physician review process.

Certification requirements for pharmacists dispensing PEP include an active pharmacy license, a Doctor of Pharmacy degree or at least 3 years of experience, minimum $250,000 liability coverage, and completion of a board-approved course covering patient assessments, point-of-care testing, contraindications, and comorbidity identification.

Pharmacies with pharmacists operating under collaborative practice agreements must submit annual access-to-care plans to the Board of Pharmacy and Department of Health, including protocols for referring patients who lack primary care access to federally qualified health centers, county health departments, or other care settings.

Officially cited as the "John W. Rheay Act," the bill creates s. 465.1861, Florida Statutes, and took effect July 1, 2024.